BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16630141)

  • 1. Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.
    Doi M; Yokoyama A; Kondo K; Ohnishi H; Ishikawa N; Hattori N; Kohno N
    Cancer Sci; 2006 May; 97(5):420-9. PubMed ID: 16630141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1.
    Namba M; Hattori N; Hamada H; Yamaguchi K; Okamoto Y; Nakashima T; Masuda T; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Kohno N
    Cancer Lett; 2019 Feb; 442():31-39. PubMed ID: 30389434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
    Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of sialylated epitope recognized by KL-6 monoclonal antibody in ocular surface epithelium of normals and dry eye patients.
    Hayashi Y; Kao WW; Kohno N; Nishihara-Hayashi M; Shiraishi A; Uno T; Yamaguchi M; Okamoto S; Maeda M; Ikeda T; Hamada H; Kondo K; Ohashi Y
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2212-7. PubMed ID: 15223797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
    Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
    Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 12. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
    Zhang K; Baeckström D; Brevinge H; Hansson GC
    J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
    Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
    World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
    Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interstitial lung disease and lung cancer].
    Ishikawa N; Kohno N
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):6-9. PubMed ID: 20087026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth.
    Katayose Y; Kudo T; Suzuki M; Shinoda M; Saijyo S; Sakurai N; Saeki H; Fukuhara K; Imai K; Matsuno S
    Cancer Res; 1996 Sep; 56(18):4205-12. PubMed ID: 8797593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.
    Kondo K; Kohno N; Yokoyama A; Hiwada K
    Cancer Res; 1998 May; 58(9):2014-9. PubMed ID: 9581847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.
    Wesseling J; van der Valk SW; Vos HL; Sonnenberg A; Hilkens J
    J Cell Biol; 1995 Apr; 129(1):255-65. PubMed ID: 7698991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
    Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
    Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.